Zantac Buyers Will Appeal Sanofi Dismissal From Conn. Suit
By Aaron Keller · September 9, 2025, 8:43 PM EDT
Hundreds of out-of-state purchasers of the heartburn drug ranitidine, the generic form of Zantac, have signaled plans to appeal a Connecticut judge's dismissal of negligent design claims against Sanofi-Aventis U.S. LLC,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login